Leveraging decades of manufacturing excellence, Cadila Pharma produces high-quality Sulfolane, supported by robust processes and dependable supply capabilities.
Technology Advantage - Reduced dependency on global players in the area of aromatic/hydrocarbon extraction, e.g. UOP, Shell, Lurgi, Krupp Koppers, etc.
New hydrocarbon processing units, oil refineries, and pharmaceutical plants will create employment opportunities for engineers and plant operators.
Removal of benzene from gasoline blending streams, reducing exposure to this highly carcinogenic compound.
The technology enables the production of valuable petrochemicals such as Benzene, Toluene, and Xylene from refinery and petrochemical feedstocks.
1994
Established the Speciality Chemicals Division for Sulfolane manufacturing.
1996
The plant became fully operational and commenced commercial production.
1997
Received the National Award for Comprehensive Chemical Technology Research in collaboration with CSIR-IIP, Dehradun.
1997 - 2015
Successfully served domestic market demand.
2016 - 2024
Expanded production capacity in response to growing market demand.
Cadila Pharma is the only manufacturer of Sulfolane in India, and it can service major domestic and export requirements.

Sulfolane is also known as:
Features
Availability
Packing
From aromatic extraction to acid gas treatment and advanced distillation, Sulfolane supports complex industrial operations where efficiency, selectivity, and stability matter most.

CAS No. : 126-33-0
CAS No. : 77-79-2
For inquiries related to Sulfolane, please reach out to:
Our Story
Businesses
Therapies
Corporate Identification No : U24231GJ1991PLC015132
©2026 Cadila Pharmaceuticals. All rights reserved